Universal Ibogaine Inc.

C$0.01As of Sun 8 Nov 2026, 12:00 UTC
TSXV:IBOHealthcare
Country Canada
PE (Fwd) •••
TSR 5Y CAGR (51.02%)
Div yield —
ROE (161.37%)
Biotechnology
Beta (5Y) 4.22
PE TTM —
TSR TTM —
Mkt cap C$1.564M
ROIC (12.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0048
(4.13%)
(31.19%)
Hold 9|6|4|9|9
1Q26
2Q26
3Q26
4Q26
Earnings per share$
—
—
—
—
24.08%
17.63%
12.97%
7.65%
Revenue$M
0.163
0.163
0.165
0.172
10.20%
6.86%
2.18%
5.28%
Peers (US$1.107M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.240
0.020
0.017
EBIT/Intx
0.764
0.051
0.050
Own earn%
18.44
46.75
40.79
Sh yield%
9.59
39.15
40.08
Owners
Insiders/Inst%
8.25
81.42
Short interest%
4.58
SBC / revenue%
1.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
18–26
$1 testx
0.0
Incr. ROIC%
24